/
Global AMR R&D HUB / Publication / Reports

Reports

Market Incentives Guide: Which economic pull incentive may be right for your country?
Reports

Market Incentives Guide: Which economic pull incentive may be right for your country?

01.09.2023: It is widely recognized that pull – or other types of market incentives – will have a transformative impact […]

nupur
A shared dialogue on pull incentives
Reports

A shared dialogue on pull incentives

03.08.2023: On the 27th April 2023, The Global AMR R&D Hub’s Members, Observers and Stakeholder Group held a shared dialogue […]

nupur
Incentivising the development of new antibacterial treatments: Progress report by the Global AMR R&D Hub and WHO 2023
Reports

Incentivising the development of new antibacterial treatments: Progress report by the Global AMR R&D Hub and WHO 2023

14.05.2023: In 2021 and 2022, G7 Finance and Health Ministers committed to expedite implementation of existing antimicrobial resistance (AMR) strategies, […]

nupur
The impact of AMR on cancer care – new article
Reports

The impact of AMR on cancer care – new article

19.10.2022: Antimicrobial resistance (AMR) presents a significant challenge for cancer patients, with 1 in 5 requiring hospitalisation due to infection. […]

Marcus Smolarek
The Global AMR R&D Hub – At a Glance
Reports

The Global AMR R&D Hub – At a Glance

20.06.2022: Read our latest studies & policy briefs, and make sure to utilise our Dynamic Dashboard, offering in-depth knowledge on […]

nupur
Incentivising the development of new antibacterial treatments: Progress report by the Global AMR R&D Hub and WHO
Reports

Incentivising the development of new antibacterial treatments: Progress report by the Global AMR R&D Hub and WHO

Following the call to action in December 2021 under the UK’s G7 Presidency, the Global AMR R&D Hub and WHO […]

Marcus Smolarek
Launch of the Cross-sector report on One Health
Reports

Launch of the Cross-sector report on One Health

05.04.2022: Our Dynamic Dashboard continues to expand with the launch of the Cross-Sector Report on One Health! In April 2021, […]

Marcus Smolarek
Annual Report 2021 – now available!
Reports

Annual Report 2021 – now available!

09.11.2021: We have just published our ‘Annual Report 2021: The Global AMR R&D Funding Landscape’. The report provides a global […]

Marcus Smolarek
Report on Animal health R&D in LMICs – November 2021
Reports

Report on Animal health R&D in LMICs – November 2021

The Animal Health AMR R&D Landscape in Low and Middle-Income Countries:

nupur
Joint Statement on Strengthening the Antibiotic R&D Pipeline by Rewarding Innovation
Reports

Joint Statement on Strengthening the Antibiotic R&D Pipeline by Rewarding Innovation

17.11.2021: 20 national and international organisations from academia, healthcare, global health and the pharmaceutical industry – including the Global AMR […]

Marcus Smolarek
Funded by: